122 related articles for article (PubMed ID: 16083309)
1. Effect of cardiac lymph flow obstruction on cardiac collagen synthesis and interstitial fibrosis.
Kong D; Kong X; Wang L
Physiol Res; 2006; 55(3):253-258. PubMed ID: 16083309
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot.
Lai CT; Chan KW; Wong SJ; Chow PC; Cheung YF
Am Heart J; 2011 Sep; 162(3):467-73. PubMed ID: 21884862
[TBL] [Abstract][Full Text] [Related]
4. Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.
Nagao K; Inada T; Tamura A; Kajitani K; Shimamura K; Yukawa H; Aida K; Sowa N; Nishiga M; Horie T; Makita T; Ono K; Tanaka M
ESC Heart Fail; 2018 Dec; 5(6):1044-1051. PubMed ID: 30273997
[TBL] [Abstract][Full Text] [Related]
5. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
[TBL] [Abstract][Full Text] [Related]
6. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
Kobayashi M; Girerd N; Ferreira JP; Kevin D; Huttin O; González A; Bozec E; Clark AL; Cosmi F; Cuthbert J; Diez J; Edelmann F; Hazebroek M; Heymans S; Mariottoni B; Pellicori P; Petutschnigg J; Pieske B; Staessen JA; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1559-1568. PubMed ID: 35703355
[TBL] [Abstract][Full Text] [Related]
7. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation.
Swartz MF; Fink GW; Sarwar MF; Hicks GL; Yu Y; Hu R; Lutz CJ; Taffet SM; Jalife J
J Am Coll Cardiol; 2012 Oct; 60(18):1799-806. PubMed ID: 23040566
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Procollagen C-Proteinase Enhancer 1 in Mice has No Major Impact on Cardiac Collagen and Function Under Basal Conditions.
Sansilvestri-Morel P; Harouki-Crochemore N; Bertin F; Bertheux H; Vermeil de Conchard G; Diguet N; Desfosses E; Lecomte M; Gonzalez A; Diez J; Tupinon-Mathieu I; Delerive P
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e703-e713. PubMed ID: 34369899
[TBL] [Abstract][Full Text] [Related]
9. Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction.
Osokina A; Karetnikova V; Polikutina O; Ivanova A; Gruzdeva O; Dyleva Y; Kokov A; Brel N; Pecherina T; Barbarash O
Aging (Albany NY); 2021 Jan; 13(1):194-203. PubMed ID: 33431713
[TBL] [Abstract][Full Text] [Related]
10. Plasma nitric oxide and left ventricular function in rabbits after cardiac lymphatic obstruction.
Wang YL; Wang XH; Jin Y; Kong DG; Wang LX
Bosn J Basic Med Sci; 2011 Feb; 11(1):17-9. PubMed ID: 21342136
[TBL] [Abstract][Full Text] [Related]
11. Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.
Radovan J; Vaclav P; Petr W; Jan C; Michal A; Richard P; Martina P
Mol Cell Biochem; 2006 Dec; 293(1-2):71-8. PubMed ID: 16933032
[TBL] [Abstract][Full Text] [Related]
12. Effect of High Thoracic Sympathetic Nerve Block on Serum Collagen Biomarkers in Patients with Chronic Heart Failure.
Sun G; Liu F; Qu R
Cardiology; 2017; 136(2):102-107. PubMed ID: 27591776
[TBL] [Abstract][Full Text] [Related]
13. Relations between markers of cardiac remodelling and left ventricular collagen in an isoproterenol-induced heart damage model.
Adamcova M; Baka T; Dolezelova E; Aziriova S; Krajcirovicova K; Karesova I; Stanko P; Repova K; Simko F
J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31019126
[TBL] [Abstract][Full Text] [Related]
14. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency.
Uusimaa P; Risteli J; Niemelä M; Lumme J; Ikäheimo M; Jounela A; Peuhkurinen K
Circulation; 1997 Oct; 96(8):2565-72. PubMed ID: 9355895
[TBL] [Abstract][Full Text] [Related]
15. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
Ho CY; López B; Coelho-Filho OR; Lakdawala NK; Cirino AL; Jarolim P; Kwong R; González A; Colan SD; Seidman JG; Díez J; Seidman CE
N Engl J Med; 2010 Aug; 363(6):552-63. PubMed ID: 20818890
[TBL] [Abstract][Full Text] [Related]
16. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
17. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
[TBL] [Abstract][Full Text] [Related]
18. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
[TBL] [Abstract][Full Text] [Related]
19. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
[TBL] [Abstract][Full Text] [Related]
20. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
